| Company Needs to Raise Substantial Capital to Continue Operations EMERYVILLE, Calif., March 30, 2012 /PRNewswire/ -- Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced financial results for the year ended December 31, 2011. (Logo: http://photos.prnewswire.com/prnh/20111110/SF04662LOGO) "In 2011 we initiated our Phase 3 trial for Menerba for the treatment of menopausa...continued BNVI menopause pharmaceutical clinical |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment